PR Newswire (press release) Xarelto benefits from its first-to-market advantage for VTE treatment/secondary prophylaxis, the removal of the need for bridging with a low-molecular-weight heparin in the VTE treatment/secondary prophylaxis setting and once-daily dosing. Bristol ... and more »
Wall Street Journal In a letter to Smithfield CEO Larry Pope, Mr. Upton and five of his GOP colleagues claim that the sale "raises questions related to the safety and ad...
Family Practice News Digital Network LONDON – Low-molecular-weight heparin therapy reduced the risk for recurrent implantation failure, improved pregnancy rates, and increased the number of live births in women who had failed prior fertility treatment in a 126-patient pilot study. As ... and more »
PR Newswire (press release) Risk factors for bleeding include concomitant use of medications that increase the risk of bleeding (e.g., anti-platelet agents, heparin , fibrinolytic therapy, and chronic use of NSAIDs). PRADAXA's anticoagulant activity and half-life are increased in ... and more »
